logo
#

Latest news with #You'llBeBack

From Hamilton's 'You'll Be Back' to backfiring tariffs – the long legacy of US trade barriers
From Hamilton's 'You'll Be Back' to backfiring tariffs – the long legacy of US trade barriers

IOL News

time3 days ago

  • Politics
  • IOL News

From Hamilton's 'You'll Be Back' to backfiring tariffs – the long legacy of US trade barriers

For anyone who has seen the Broadway musical, Hamilton, which tells the life-story of one of the US' founding fathers, you'll be more familiar with the scene in which 'King George III' sings 'You'll Be Back' in response to the American Revolutionary War than Alexander Hamilton's role in tariffs. Yet, Hamilton was key in what must be one of the oldest tariff proposals in the US' history. In 1789, he communicated the Act Laying Duties on Imports was to the United States House of Representatives, proposing that imported goods be more expensive, which would force Americans to buy more homemade products and boost the local manufacturing sector. While the direct results of Hamilton's tariffs are lost to history, this Act was followed by many more. In fact, the US has a long history of imposing import duties, with serious – yet unintended – negative consequences. The latest trade war is due to US President Donald Trump's recent imposition of tariffs, which varied widely from his first 'Liberation Day' announcement and have already been extended beyond August 1 for negotiations – except for South Africa and other countries that received a letter. In a 1976 paper detailing the background and emergence of the US Trade Commission, author John Dobson commented amid its 146 pages that: 'Perhaps the safest conclusion one can draw from a study of tariffs in general, and the history of the US tariff in particular, is that change, and controversy are ever present and perhaps inevitable.'

Quincy, a city full of history, celebrates 400 years
Quincy, a city full of history, celebrates 400 years

Boston Globe

time7 days ago

  • Entertainment
  • Boston Globe

Quincy, a city full of history, celebrates 400 years

Advertisement Ever since he was a child, John Rahman remembers his parents taking him to see the Abigail Adams statue in Quincy Center every Fourth of July. Attendees at the Quincy 400 celebration were fascinated by the TEN31 Productions living statues that impersonated John Adams and Abigail Adams on July 6, 2025. Heather Diehl for the Boston Glo Rahman, 37, grew up several miles away in Norwell, but he says his parents were diligent about teaching him about the area's history. On Sunday afternoon, he kept the tradition alive by standing in front of the Abigail Adams statue — 'I've always liked that Quincy celebrates its heritage,' Rahman said. Now a Quincy resident himself, Rahman also cherishes the city's history. He keeps a three-foot statue of John Quincy Adams in his apartment to remind him of his late father, who received the statue as a gift after working on its life-sized counterpart. Advertisement 'It helps me remember my city's history and my own history,' he said. The afternoon began with a series of American history-themed musical theater songs, including 'Sit Down, John' from '1776,' 'You'll Be Back' from 'Hamilton,' and 'Back to Before' from 'Ragtime,' each preceded by historical facts about Quincy. Afterwards, the Lexington Minutemen and Boston Alarm Company Fife & Drum took the stage dressed in Revolutionary War-era garb to perform a period-accurate march, and the evening promised entertainment from the Beantown Swing Orchestra and the Boston Lindy Hop Dancers. For Mary Ryan, 80, the celebration was as much a chance to honor Quincy's history as it was to enjoy the warm weather and slight breeze from her lawn chair. Richard Davia, Nick D'Amico and Ellen Olivers of TEN31 Productions, dress up as a statues of John Adams, John Hancock and Abigail Adams outside of Quincy City Hall during the 400th anniversary celebration of Quincy, MA on July 6, 2025. Heather Diehl for the Boston Glo 'I once lived in a house that was built in 1776 in Pembroke, and ever since then I've been interested in history. And Quincy has a lot of it,' said the retiree, who also proudly claimed membership in the Quincy Historical Society. Hancock Adams Common itself is rich with landmarks that boast Quincy's long history. As a volunteer tour guide at Although Tanner originally hails from Ohio, she's lived in Quincy for about 30 years and knows its history like the back of her hand. 'Quincy treasures its past,' she said. 'Living here made me want to learn its history.' Advertisement

Arnold Schwarzenegger's vital step for full health past your 50s
Arnold Schwarzenegger's vital step for full health past your 50s

Daily Mirror

time22-05-2025

  • Health
  • Daily Mirror

Arnold Schwarzenegger's vital step for full health past your 50s

The 77-year-old assured you don't need to stick to his rigorous routine to age healthily "If you rest, you rust" declared Arnold Schwarzenegger, who at 77 is sharing the best thing he did in his 50s to maintain health while ageing. Speaking at the CNBC CEO Council Summit in Arizona, the actor emphasised the importance of staying active: "It is extremely important to not stop moving when you're 50 or 60 just because of joint problems. "If you stop movement, then this is the first step to death. If you rest, you rust." ‌ He stressed that continuing to move is key to healthy ageing, particularly in one's 50s and 60s. The intensity of the activity isn't the focus, though, as Schwarzenegger assured fans don't need to be taking on his personal routine. ‌ The iconic Terminator actor suggested: "Do something. It doesn't matter to me if you play tennis, if you go skiing, if you play soccer, or if you lift do something." Arnold's advice is testament to his new role as Chief Movement Officer for Zimmer Biomet, a position he accepted last year. Ever since, he's been using his platform to help people overcome their fear of medical technology which is holding them back from exercising in later life. Despite his portrayals of indestructible characters on the big screen, Schwarzenegger has weathered several serious health challenges. He has undergone two open-heart surgeries to replace parts of his heart and just last year was fitted with a pacemaker due to a genetic heart condition. He's also undergone a hip replacement, which he's turned into a positive message with his ' You'll Be Back ' campaign. He commented: "I want to let people know and give them the courage to get those things fixed and continue moving. Don't let anything get in the way. Exercise, exercise, exercise." The campaign aims to motivate people to stop avoiding treatment, re-engage with physical activity, and enhance their overall health as they grow older. This is especially pertinent for the one in four Americans who suffer from knee pain. ‌ According to CNBC, the Austrian celebrity maintains a daily fitness regimen that includes an hour of cycling and 45 minutes of weight training. His extensive gym experience has led to some insightful reflections. He recalled hearing many people complaining about having to skip exercises or adjust their routines as they were told they'd need procedures like shoulder replacements. However, they were afraid of the surgery and opted to let their exercise suffer instead o getting treatment. The ex-governor stressed that surgery should not be the first solution for joint issues. However, he pointed out that many are unaware of the remarkable technological advancements at their disposal. Reflecting on his own hip surgery, he remembered: "When I did it, I had to stay in the hospital for days and had months of therapy." In comparison, he said current technologies can enable patients to "walk out" after the operation.

ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues

Yahoo

time19-05-2025

  • Business
  • Yahoo

ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues

Zimmer Biomet's ZBH strategic priorities, new product launches and focus on international expansion bolster our confidence in this stock. Yet, the difficult macroeconomic situation and FX issues are concerning. The stock carries a Zacks Rank #3 (Hold). Despite challenging market conditions in the form of pricing pressure, the last few quarters witnessed gradual stability in the global musculoskeletal market with better-than-expected sales growth in certain geographies, banking on improved procedural volume. This was driven by favorable demographics and growing utilization of musculoskeletal healthcare in emerging markets and under-penetrated developed markets. The focused execution of the company's global sales teams amid a stable global musculoskeletal market also helped accelerate global sales for Persona, the personalized knee line with this, in the first quarter of 2025, the company witnessed strong growth driven by continued procedure growth, strong execution, and solid momentum with the new innovation. The company saw another positive quarter of year-over-year momentum in large joints, with the overall global Knees, Hips and S.E.T. business growing 1.9%, 2.4% and 4.9%, respectively, at a constant exchange rate. Zimmer Biomet is pursuing a disciplined, four-pillar expansion strategy to achieve a 5% weighted average market growth rate by 2027. First, the company is boosting patient awareness through its 'You'll Be Back' campaign, fronted by chief movement officer Arnold Schwarzenegger. It partners with global medical societies and ramps up digital outreach to encourage the 95% of osteoarthritis sufferers who never seek care. Second, Zimmer Biomet is tackling safety. New iodine surface-treated hip implants, which have debuted in Japan and are slated for launch in the United States, aim to curb periprosthetic joint infections that can carry a higher mortality risk than certain Zimmer Biomet is improving efficiency through smart implants, CT-optional ROSA Robotics, and AI-powered OrthoGrid—streamlining workflows, cutting costs, and boosting surgical capacity. Finally, Zimmer Biomet is elevating outcomes. The newly approved Oxford Partial Cementless Knee shows 93% 10-year survivorship versus 90% for cemented versions in 15,000 UK patients. Zimmer Biomet Holdings, Inc. price | Zimmer Biomet Holdings, Inc. Quote Selective acquisitions remain part of the strategy, backed by solid integration capabilities and a strong balance sheet. In this regard, Zimmer Biomet completed its acquisition of Paragon 28 in April, expanding its presence in the foot and ankle market. The deal is expected to add 270 basis points to Zimmer Biomet's sales growth in 2025. Over the past three months, shares of ZBH have declined 6.3% against the industry's 1.5% gain. With the company consistently focusing on strategic market expansion and new product launches, we expect the stock to regain momentum in the coming days. The ongoing industry-wide trend of staffing shortages and supply chain-related hazards is denting growth for Zimmer Biomet. Deteriorating international trade and geopolitical complications lead to a tough situation related to raw material and labor costs, as well as freight charges. Added to this, high policy rates to fight inflation, along with the gradual withdrawal of fiscal policies amid high debt, continue to dent economic growth, impacting the overall market situation for Zimmer Biomet. Within the Hip category, headwinds in Russia are disproportionately impacting the outside U.S. business. Further, within the S.E.T. category, Zimmer Biomet is facing challenges in the form of reimbursement headwinds, particularly in the Restorative Therapies business. Concerning the ongoing tariff issue, Zimmer Biomet expects a $60–$80 million impact on 2025 operating profit, mainly in the second half, factoring in mitigation efforts and anticipated European reciprocal tariffs. Combined with the Paragon 28 acquisition, this is expected to reduce full-year adjusted operating margins by 100–150 basis points versus 2024. Our model projects a 7.7% and 6.6% increase in the company's cost of product sold and selling, general and administrative expenses for 2025. A substantial portion of Zimmer Biomet's foreign revenues is generated in Europe and Japan. In recent times, significant increases in the value of the U.S. dollar relative to the euro, the Japanese yen, the Swiss Franc, or other currencies have accordingly had an adverse effect on the company's results of operations. In the first quarter of 2025, Zimmer Biomet's net sales were affected by 1.2% from changes in foreign exchange rates. Some better-ranked stocks in the broader medical space include Hims & Hers Health HIMS, Boston Scientific BSX and Cardinal Health CAH. Each of these carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Estimates for Hims & Hers Health's 2025 earnings per share have jumped 21.2% to 63 cents in the past 30 days. Shares of the company have surged 247.6% in the past year compared with the industry's 19.9% growth. Its earnings yield of 1.1% compares comfortably with the industry's -9.7% yield. HIMS' earnings surpassed estimates in two of the trailing four quarters, matched in one and missed on another occasion, the average surprise being 19.6%. Boston Scientific shares have rallied 40.7% in the past year. Estimates for the company's 2025 earnings per share have jumped 2.1% to $2.91 in the past 30 days. BSX's earnings beat estimates in each of the trailing four quarters, the average surprise being 8.8%. In the last reported quarter, it posted an earnings surprise of 11.9%. Estimates for Cardinal Health's fiscal 2025 earnings per share have increased 2% to $8.09 in the past 30 days. Shares of the company have jumped 56.4% in the past year against the industry's 0.8% fall. CAH's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 910.3%. In the last reported quarter, it delivered an earnings surprise of 9.3%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX) : Free Stock Analysis Report Cardinal Health, Inc. (CAH) : Free Stock Analysis Report Zimmer Biomet Holdings, Inc. (ZBH) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Leslie Odom Jr. announces return to ‘Hamilton' on Broadway
Leslie Odom Jr. announces return to ‘Hamilton' on Broadway

NBC News

time14-04-2025

  • Entertainment
  • NBC News

Leslie Odom Jr. announces return to ‘Hamilton' on Broadway

It seems like King George III was right when he sang 'You'll Be Back': Leslie Odom Jr. will be returning to the Broadway stage to reprise his role of Aaron Burr in 'Hamilton,' he exclusively announced live on "TODAY" on Monday. Odom — who won a Tony for best leading actor in a musical in 2016 for his portrayal of Aaron Burr, as well as a Grammy for his original Broadway cast recording in 2015 — will have a limited run as the character from Sept. 9 through Nov. 23, 2025. Odom's announcement of his return comes as 'Hamilton' celebrates its 10-year anniversary on Broadway. 'Returning to 'Hamilton' is a deeply meaningful homecoming,' Odom said in a press release. 'I'm so grateful for the chance to step back into the room — especially during this anniversary moment and to revisit this brilliant piece that forever changed my life and the lives of so many.' Odom first played Burr in the off-Broadway 'Hamilton' production and joined the original cast when the show hit Broadway in August 2015. He left the show in July 2016 at the same time fellow stars Phillipa Soo and Lin-Manuel Miranda, who's also the show's creator. This will be the first time he is reprising the role on Broadway. He will take the stage at Broadway's Richard Rodgers Theatre, where 'Hamilton' has been since its Broadway debut. Odom grew particular fame from the song 'The Room Where It Happens,' which allows insight into his character's thirst for knowledge and showcases his vocal prowess. 'When I saw Leslie perform 'The Room Where It Happens' at the first act two workshop of 'Hamilton,' I knew I was witnessing a historic moment,' said Jeffrey Seller, the lead producer of 'Hamilton,' in the press release. 'How lucky we are that Leslie is returning to Hamilton and bringing his indelible Burr back to Broadway.' Since starring in 'Hamilton,' Odom has explored film, TV and other musicals, featuring in works like 'Glass Onion: A Knives Out Mystery,' 'Harriet,' 'Abbott Elementary' and making his Broadway return in the revival of 'Purlie Victorious: A Non-Confederate Romp Through the Cotton Patch.' He also released five studio albums, wrote a memoir called 'Failing Up' and co-authored a children's book with his wife called 'I Love You More Than You'll Ever Know.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store